The Efficacy of Preoperative Oral Administration of Lactobacillus Reuteri Combined With Preoperative Neoadjuvant/Conversion Immunotherapy in Patients With Primary Resectable Liver Cancer
Clinical trial NCT07306481 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07306481
- Sponsor
- Fujian Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-20
- Primary completion
- 2028-06-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.